Catalin Toma, MD, is leading a phase II multicenter clinical trial. The study will assess the safety of AMI MultiStem® in people after a recent heart attack.
AMI MultiStem vial is a cell therapy product made from adult stem cells found in bone marrow. Researchers take the stem cells from a non-related donor and expand them ex-vivo.
Trial subjects will receive MultiStem via catheter into the outer layer of the target vein after successful angioplasty.
McGowan Institute for Regenerative Medicine
450 Technology Drive
Pittsburgh, PA 15219